See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Natural Disasters
Donald Trump
Trade War
Baseball
Social Media
Stock Markets
Democratic Party
US Politics
Republican Party
Education
US Economy
Published • loading... • Updated

CRISP Secures $49 M in financing from D2 Capital Advisors

Summary by Delaware Business Times
CRISP had secured the funding for the Prelude Therapeutics Headquarters and a new hotel on its campus, with the support of D2 Capital Advisors. The post CRISP Secures $49 M in financing from D2 Capital Advisors appeared first on Delaware Business Times.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
1
Right
Delaware Business TimesDelaware Business Times
Center

CRISP Secures $49 M in financing from D2 Capital Advisors

CRISP had secured the funding for the Prelude Therapeutics Headquarters and a new hotel on its campus, with the support of D2 Capital Advisors. The post CRISP Secures $49 M in financing from D2 Capital Advisors appeared first on Delaware Business Times.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Delaware Business Times broke the news in on Thursday, April 3, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Newark, Delaware

Newark, Delaware

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal